Pearson G A, Grant J, Field D, Sosnowski A, Firmin R K
Groby Road Hospital, Leicester.
Arch Dis Child. 1993 Jan;68(1):94-6. doi: 10.1136/adc.68.1.94.
Extracorporeal membrane oxygenation (ECMO) is a life support technique based on modifications of heart-lung bypass technology. It is used to support severe but potentially reversible pulmonary or cardiopulmonary failure. There is increasing use of the technique for neonates and a return of interest in its use for adults. The number of non-neonatal paediatric patients receiving pulmonary support with ECMO worldwide is, however, small, and survival rates average less than 50%. Initial experience in 15 patients aged 3 months to 5 years with a high survival and low morbidity is reported.
体外膜肺氧合（ECMO）是一种基于心肺转流技术改良的生命支持技术。它用于支持严重但可能可逆的肺或心肺功能衰竭。该技术在新生儿中的应用越来越多，并且人们对其在成人中的应用重新产生了兴趣。然而，全球接受ECMO肺支持的非新生儿儿科患者数量较少，生存率平均不到50%。本文报告了15例年龄在3个月至5岁之间患者的初步经验，其生存率高且发病率低。
